Dr. Sudipto Das is a StAR research lecturer and principal investigator in the School of Pharmacy and biomolecular sciences, Royal College of Surgeons in Ireland (RCSI). He completed his undergraduate degree from India followed by an M.Res, University of Glasgow and a PhD in Cancer Genetics from RCSI. He started his post-doctoral career in Cancer Biology and Therapeutics laboratory, Conway Institute, UCD. During this period, he also spent time as a visiting research fellow in VIB, K.U., Leuven, VuMC, Amsterdam and Hoshi University, Tokyo Japan.

His doctoral work gave him the opportunity to develop a core expertise in the area of epigenetics focused on DNA methylation alterations and non-coding RNAs, which he further enhanced during his post-doctoral career. This has allowed Dr. Das to obtain prestigious fellowship from organizations such as the Irish Cancer Society, obtain several awards including the EACR young investigator award.

In 2019, he received the Starting investigator research grant (SIRG) award from Science Foundation Ireland (SFI) and was subsequently appointed as a StAR research lecturer at RCSI. He currently leads a team of PhD students funded by SFI and Irish Research Council. Sudipto’s research group primarily focusses on applying genomic/epigenomic approaches with an aim to identify novel predictive/prognostic biomarkers and/or therapeutic targets across various gastrointestinal diseases including Colorectal cancer and inflammatory bowel disease. He has published in various high impact journals including in Nature Comms, J Clin Onc, JCO-Precision Oncology, Cancer research, Clinical Cancer Research and JCI to name a few.